Liver transplantation is an therapeutic option increasingly common in Colombia for advanced liver disease. The survival of 80% at 5 years leads to an increased cardiovascular risk and cardiovascular events, for this reason this research determines the behavior of cardiovascular risk in patients with liver transplant Cardioinfantil Foundation. Finding there is an increased cardiovascular risk in patients three years after transplantation statistically significant, mainly secondary to hypertension, diabetes and hypertriglyceridemia. The increase is larger as described in the general population, and similar to other transplant patients over a period of 5 years.
